Literature DB >> 26903404

Regulation of FGF signaling: Recent insights from studying positive and negative modulators.

Lina Korsensky1, Dina Ron2.   

Abstract

Fibroblast growth factor (FGF) signaling is involved in a multitude of biological processes, while impairment of FGF signaling is implicated in a variety of human diseases including developmental disorders and cancer. Therefore, it is not surprising that FGF activity is regulated at multiple and distinct levels. This review focuses on positive and negative modulation of the FGF signal exemplified by recently identified protein modulators anosmin-1, fibronectin-leucine-rich transmembrane protein 3 (FLRT3) and similar expression to FGF (Sef). We examine how these proteins regulate FGF signaling at multiple levels and across species. Finally, we describe the role of these regulators in human disease.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26903404     DOI: 10.1016/j.semcdb.2016.01.023

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  13 in total

Review 1.  Feedback regulation of RTK signaling in development.

Authors:  Cynthia L Neben; Megan Lo; Natalia Jura; Ophir D Klein
Journal:  Dev Biol       Date:  2017-10-26       Impact factor: 3.582

2.  Tissue nonspecific alkaline phosphatase promotes calvarial progenitor cell cycle progression and cytokinesis via Erk1,2.

Authors:  Hwa Kyung Nam; Iva Vesela; Erica Siismets; Nan E Hatch
Journal:  Bone       Date:  2018-10-17       Impact factor: 4.398

3.  Long-Range Signaling Activation and Local Inhibition Separate the Mesoderm and Endoderm Lineages.

Authors:  Antonius L van Boxtel; Andrew D Economou; Claire Heliot; Caroline S Hill
Journal:  Dev Cell       Date:  2017-12-21       Impact factor: 12.270

4.  TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p.

Authors:  Jonathan Berrout; Eleni Kyriakopoulou; Lavanya Moparthi; Alexandra S Hogea; Liza Berrout; Cristina Ivan; Mihaela Lorger; John Boyle; Chris Peers; Stephen Muench; Jacobo Elies Gomez; Xin Hu; Carolyn Hurst; Thomas Hall; Sujanitha Umamaheswaran; Laura Wesley; Mihai Gagea; Michael Shires; Iain Manfield; Margaret A Knowles; Simon Davies; Klaus Suhling; Yurema Teijeiro Gonzalez; Neil Carragher; Kenneth Macleod; N Joan Abbott; George A Calin; Nikita Gamper; Peter M Zygmunt; Zahra Timsah
Journal:  Nat Commun       Date:  2017-10-16       Impact factor: 14.919

Review 5.  Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins.

Authors:  Marta Latko; Aleksandra Czyrek; Natalia Porębska; Marika Kucińska; Jacek Otlewski; Małgorzata Zakrzewska; Łukasz Opaliński
Journal:  Cells       Date:  2019-05-14       Impact factor: 6.600

Review 6.  FGF23, Hypophosphatemia, and Emerging Treatments.

Authors:  Erik A Imel; Andrew Biggin; Aaron Schindeler; Craig F Munns
Journal:  JBMR Plus       Date:  2019-05-13

Review 7.  Meibomian Gland Dysfunction: What Have Animal Models Taught Us?

Authors:  Mingxia Sun; Isabel Y Moreno; Michelle Dang; Vivien J Coulson-Thomas
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

Review 8.  Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Authors:  Harriet R Ferguson; Michael P Smith; Chiara Francavilla
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

9.  Delivery of the gene encoding the tumor suppressor Sef into prostate tumors by therapeutic-ultrasound inhibits both tumor angiogenesis and growth.

Authors:  Sabrin Mishel; Boris Shneyer; Lina Korsensky; Orit Goldshmidt-Tran; Tom Haber; Marcelle Machluf; Dina Ron
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

Review 10.  Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children.

Authors:  Aaron Schindeler; Andrew Biggin; Craig F Munns
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.